SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss

Clinical trial NCT01451853 · WITHDRAWN

Trial details

NCT number: NCT01451853
Sponsor: Sound Pharmaceuticals, Incorporated
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer Head and Neck Cancer Hearing Loss Ototoxicity Tinnitus Neuropathy

Start date: 2026-06-01
Primary completion: 2026-06-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.